On November 9, ISDA sent a paper to the European Commission and UK Financial Conduct Authority recommending that over-the-counter (OTC) derivatives are identified using unique product identifiers (UPIs) for EU and UK transparency requirements, augmented with some key trade-level attributes (known as UPI+). ISDA believes this would be more appropriate than ISINs because it would enable users to aggregate and perform meaningful analysis on instrument pricing across the market. These additional attributes would ensure OTC derivatives could be identified and aggregated in a way that is useful to market participants while providing sufficient granularity to distinguish between different products.
Documents (1) for ISDA Paper on Unique Product Identifiers
Latest
ISDA In Review – December 2025
A compendium of links to new documents, research papers, press releases and comment letters published by ISDA in December 2025.
Response to EC on Market Risk Prudential Framework
On January 6, ISDA, the Association for Financial Markets in Europe (AFME) and the Institute of International Finance (IIF) submitted a joint response to the European Commission’s (EC) targeted consultation on the application of the market risk prudential framework. ISDA,...
Updated OTC Derivatives Compliance Calendar
ISDA has updated its global calendar of compliance deadlines and regulatory dates for the over-the-counter (OTC) derivatives space.
Response on CCP Participation Requirements
On December 24, ISDA responded to a consultation from the European Securities and Markets Authority (ESMA) on central counterparty (CCP) participation requirements. Participation requirements for CCPs are vital for safe and efficient clearing markets, and ISDA broadly supports ESMA’s consultation...